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Familial Mediterranean fever (FMF) is the most common
autoinflammatory disease over the world. This autosomal
recessively inherited disease is due to mutations in the
gene coding for pyrin. Disease causing mutations in
the gene are associated with excessive levels of IL-1. The
clinical symptoms of inflammation are mainly in the
form of fever and serositis along with laboratory evi-
dence of persistently raised acute phase reactants,
including serum amyloid A levels. Untreated patients
suffer the consequences of chronic inflammation.
Patients who display inflammatory symptoms but who
carry one mutation only should be carefully evaluated for
the need of therapy. Colchicine is the main treatment of
FMF. Management of the patients includes following
clinical activity of the disease and acute phase reactants
on a regular basis and checking for drug compliance, and
monitoring side effects of the drug. If patients are intoler-
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